Abstract
Pseudomonas aeruginosa is essentially an aquatic micro-organism whose catholic metabolism allows it to colonize a large number of cold oligotrophic aquatic ecosystems. It was once considered to be so reliably non-pathogenic that bandages were soaked in cultures of this aerobic organism before they were used to dress deep wounds (D. W. Lambe, personal communication). Now P. aeruginosa constitutes a serious threat to the health of patients compromised by burns, extensive manipulation, instrumentation, or underlying diseases such as cystic fibrosis. The microbiological approaches that have virtually eradicated most of the acute epidemic bacterial diseases have not been notably successful in the prevention or the treatment of infections caused by this ‘modern’ opportunistic pathogen. Avoidance of contact with this ubiquitous environmental micro-organism is difficult, and immunological measures are contraindicated by the widespread observation that cystic fibrosis patients have high levels of anti-Pseudomonas antibodies but fail to clear their chronic infections. Antibiotic therapy is not particularly effective, especially in chronic infections, because the bacteria often survive within protected niduses and re-establish the infection when therapy is discontinued. Because it is apparent that the group of bacterial diseases caused by P. aeruginosa differs significantly from the classic epidemic bacterial diseases, and because the preventive and therapeutic strategies developed by microbiologists to counteract epidemic diseases have largely failed to prevent or cure these ‘modern’ opportunistic P. aeruginosainfections, we have adopted a radically different approach, viz. that of the microbial ecologist.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Anwar, H., Brown, M. R. W., Day, A. and Weller, P. H. (1985) Outer membrane antigens of mucoid Pseudomonas aeruginosa isolated directly from the sputum of a cystic fibrosis patient. FEMS Microbiol. Lett. 24, 235–9.
Auerbach, H. S., Williams, M., Kirkpatrick, J. A. and Colten, H. R. (1985) Alternate day prednisolone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet ii, 686–8.
Brown, M. R. W. and Williams, P. (1985a) The influence of the environment on envelope properties affecting the survival of bacteria in infections. Annu. Rev. Microbiol. 39, 527–56.
Brown, M. R. W. and Williams, P. (1985b) Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents. J. Antimicrob. Chemother. 15 ( Suppl. A), 7–14.
Brown, M. R. W., Anwar, H. and Lambert, P. A. (1984) Evidence that mucoid Pseudomonas aeruginosa in the cystic fibrosis lung grows under iron-depleted conditions. FEMS Microbiol. Lett. 21, 113–17.
Brown, M. R. W., Allison, D. G. and Gilbert, P. (1988) Resistance of bacterial biofilms to antibiotics: a growth-related effect? J. Antimicrob. Chemother. 22, 777–83.
Bryers, J. D. and Characklis, W. G. (1981) Early fouling biofilm formation in a turbulent flow system: overall kinetics. Water Res. 15, 483–91.
Cash, H. A., Woods, D. E., McCullough, B., Johanson, W. G., Jr and Bass, J. A. (1979) A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am. Rev. Resp. Dis. 119, 453–9.
Chan, R., Lam, J. S., Lam, K. and Costerton, J. W. (1984) Influence of culture conditions on expression of the mucoid form of growth of Pseudomonas aeruginosa. J. Clin. Microbiol. 19, 8–16.
Cochrane, D. M. G., Brown, M. R. W., Anwar, II., Weller, P. H., Lam, K. and Costerton, J. W. (1988) Antibody response to Pseudomonas aeruginosa surface protein antigens in a rat model of chronic lung infection. J. Med. Microbiol. 27, 255–61.
Costerton, J. W., Cheng, K.-J., Geesey, G. G., Ladd, T. I., Nickel, J. C., Dasgupta, M. K. and Marrie, T.J. (1987) Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 41, 299–324.
Dasgupta, M. K., Lam, J., Doring, G., Harley, F. L. and Zuberbuhler, P. (1987a) Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis. J. Clin. Lab. Invest. 23, 25–30.
Dasgupta, M. K., Zuberbuhler, P., Abbi, A., Harley, F. L., Brown, N. E., Lam, K., Dossetor, J. B. and Costerton, J. W. (1987b) Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis. J. Clin. Immunol. 7, 51–8.
Donzis, P. B., Mondino, B. J., Weissman, B. A. and Bruckner, D. A. (1987) Microbial contamination of contact lens care systems. Am. J. Ophthamol. 104, 325–33.
Döring, G. and Høiby, N. (1983) Longitudinal study of immune response to Pseudomonas aer uginosa antigens in cystic fibrosis. J. Infect. Dis. 147, 744–8.
Geesey, G. G., Mutch, R., Costerton, J. W. and Green, R. B. (1978) Sessile bacteria: an important component of the microbial population in small mountain streams. Limnol. Oceanogr. 23, 1214–23.
Gilbert, P., Brown, M. R. W. and Costerton, J. W. (1987) Inocula for antimicrobial sensitivity testing: a critical review. J. Antimicrob. Chemother. 20, 147–54.
Govan, J. R. W. and Harris, G. S. (1986) Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol. Sci. 3, 302–8.
Jolley, J. G., Geesey, G. G., Hankins, M. R., Wright, R. B. and Wichlarz, P. L. (1988) Auger electron spectroscopy and X-ray photoelectron spectroscopy of the biocorrosion of copper by gum arabic, bacterial culture supernatant and Pseudomonas atlantica exopolymer. Surface Interface Anal. 11, 371–6.
Lam, J. S., Chan, R., Lam, K. and Costerton, J. W. (1980) The production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 42, 88–98.
Lock, M. A., Wallace, R. R., Costerton, J. W., Ventullo, R. M. and Charlton, S. E. (1984) River epilithon: towards a structural model. Oikos 42, 10–22.
Malone, J. S. and Caldwell, D. E. (1983) Evaluation of surface colonization kinetics in continuous culture. Microb. Ecol. 9, 299–306.
Nickel, J. C., Ruseska, I., Wright, J. B. and Costerton, J. W. (1985) Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob. Agents Chemother. 27, 619–24.
Ombaka, E. A., Cozens, R. M. and Brown, M. R. W. (1983) Influence of nutrient limitation of growth on stability and production of virulence factors of mucoid and non-mucoid strains of Pseudomonas aeruginosa. Rev. Infect. Dis. 5 (Suppl. 5), S880–7.
Pennington, J. E., Small, G. J., Lostrom, M. E. and Pier, G. B. (1986) Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia. Infect. Immun. 54, 239–44.
Pier, G. B., Saunders, J. M., Ames, P., Edwards, M. S., Auerbach, H., Goldfarb, J., Speert, D. P. and Hurwitch, S. (1987) Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older non-colonized patients with cystic fibrosis. New Engl. J. Med. 317, 793–8.
Ruseska, I., Robbins, J., Lashen, E. S. and Costerton, J. W. (1982) Biocide testing against corrosion-causing oilfield bacteria helps control plugging. Oil Gas J. 3, 253–64.
Schiøtz, P. O. (1982) Systemic and mucosal immunity and non-specific defense mechanisms in cystic fibrosis patients. Acta Paediatr. Scand. Suppl. 301, 55–62.
Thurow, H., Nieman, H., Rudolph, C. and Stirm, S. (1974) Host capsule depolymerase activity of bacteriophage particles active on Klebsiella K20 and K24 strains. Virology 58, 306–9.
Tuomanen, E., Cozens, R., Tosch, W., Zak, O. and Tomasz, A. (1986) The rate of killing of Escherichia coli by p-lactam antibiotics is strictly proportional to the rate of bacterial growth. J. Gen. Microbiol. 132, 1297–1304.
White, D. C. (1986) Environmental effects testing with quantitative microbial analysis: chemical signatures correlated with in situ biofilm analysis by FT/IR. Toxicity Assessment 1, 315–38.
Woods, D. E. and Bryan, L. E. (1985) Studies on the ability of alginate to act as a protective immunogen against Pseudomonas aeruginosa in animals. J. Infect. Dis. 151, 581–8.
Woods, D. E. and Iglewski, B. H. (1983) Toxins of Pseudomonas aeruginosa: new perspectives. Rev. Infect. Dis. 131, 688–91.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Chapman and Hall
About this chapter
Cite this chapter
Costerton, J.W., Brown, M.R.W., Lam, J., Lam, K., Cochrane, D.M.G. (1990). The microcolony mode of growth in vivo — an ecological perspective. In: Gacesa, P., Russell, N.J. (eds) Pseudomonas Infection and Alginates. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1836-8_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-1836-8_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7319-6
Online ISBN: 978-94-009-1836-8
eBook Packages: Springer Book Archive